NCT00003732View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 1998

Study Completion Date

September 30, 2005

Conditions
Ovarian Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

topotecan hydrochloride

Trial Locations (1)

2100

Rigshospitalet - Copenhagen University Hospital, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00003732 - Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer | Biotech Hunter | Biotech Hunter